EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.” - European Medical Journal

EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

Bonus Episode

EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

Discussing presentations from experts Georg Schett, Freidrich-Alexander University, Erlangen-Nürnberg, Germany; Stefan Siebert, University of Glasgow, UK; and Christopher Griffiths, University of Manchester, UK, the first podcast reviews evidence exploring the potential of the IL-23 pathway in PsA. The discussions highlight both the role highlight both the role of the IL-23 pathway in the pathogenesis of PsA and the potential IL-23 inhibitors hold for improving PsA outcomes.

Spotify | Apple | AcastDownload MP3 (mp 11:35 mins)

 

This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Elevating the quality of healthcare globally

Elevating the quality of healthcare globally